| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/18/2008 | US20080227742 Photocleavable oligonucleotide and uses thereof |
| 09/18/2008 | US20080227739 Isolated polypeptide comprising amino acid sequence encoded by polynucleotide; physiologically acceptable carriers and immunostimulants |
| 09/18/2008 | US20080227735 Nucleic acid is contactd with cells not expressing receptor protein-tyrosine kinase or expressing it in a nonactivated form (CN cells), contacting first subset S1 of nucleic acids with Ci cells, contacting second subset S2 with CTe cells, amplifying nucleic acids; identifying ligands or aptamers |
| 09/18/2008 | US20080227734 Mutant Lrp5/6 Wnt-Signaling Receptors in Cancer Diagnosis, Prognosis, and Treatment |
| 09/18/2008 | US20080227719 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227718 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227712 Polypeptide for use in treatment and prevention of leukemia, hemophilia and nervous system disorders |
| 09/18/2008 | US20080227699 Therapeutic Agent for Neurodegenerative Diseases |
| 09/18/2008 | US20080227695 reduced expression and/or function of Dlg (discs large) is an important factor for tumor formation; measuring the expression and/or function of Dlg |
| 09/18/2008 | US20080227661 Mutant reverse transcriptase and methods of use |
| 09/18/2008 | US20080227659 Incrementally Truncated Nucleic Acids and Methods of Making Same |
| 09/18/2008 | US20080227653 Expression monitoring by hybridization to high density oligonucleotide arrays |
| 09/18/2008 | US20080227650 Incrementally Truncated Nucleic Acids and Methods of Making Same |
| 09/18/2008 | US20080227199 Method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 09/18/2008 | US20080227195 Expanding the eukaryotic genetic code |
| 09/18/2008 | US20080227194 Lipolytic enzyme specific antibody for use in diagnosis of pancreatitis |
| 09/18/2008 | US20080227192 Nematode ATP Synthase Subunit E-Like Sequences |
| 09/18/2008 | US20080227178 Polypeptide factor from a thermophilic eubacterial species and use thereof in the production of functional, heterologous proteins in an expression host |
| 09/18/2008 | US20080227169 Immobilization |
| 09/18/2008 | US20080227163 Production of L-ribose and other rare sugars |
| 09/18/2008 | US20080227159 Compositions and Methods Using Split Polymerases |
| 09/18/2008 | US20080227156 Nucleotide sequences coding myostatin epitopes for use in treatment and prevention of diabetic disorders; immunotherapy |
| 09/18/2008 | US20080227155 Pegylated soluble gp130-dimers useful as a medicament |
| 09/18/2008 | US20080227154 Protein Expression |
| 09/18/2008 | US20080227151 Method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 09/18/2008 | US20080227149 Interferon-Alpha Polypeptides and Conjugates |
| 09/18/2008 | US20080227148 Aspergillus Promotors for Expressing a Gene in a Fungal Cell |
| 09/18/2008 | US20080227131 P38 mitogen activated protein kinase fusion for use as reporter molecule in enzyme activation bioassays |
| 09/18/2008 | US20080227127 Human NK3-Related Prostate Specific Gene-1 |
| 09/18/2008 | US20080227125 Using cardiovascular disorder plasma polypeptides (CPPs) as evaluative tools in detection coronary artery disease |
| 09/18/2008 | US20080227110 Expression vector comprising nucleotide sequences coding human polypeptide for use in treatment of metabolic disorders; immunotherapy |
| 09/18/2008 | US20080227104 Primer, primer set, and nucleic acid amplification method and mutation detection method using the same |
| 09/18/2008 | US20080227097 Fluorescent protein and chromoprotein |
| 09/18/2008 | US20080227087 Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ types xi to xx |
| 09/18/2008 | US20080226679 Novel surface exposed proteins from chlamydia pneumoniae |
| 09/18/2008 | US20080226662 Nucleotide sequences coding mammalian immune system modulator (B7-DC) for use in treatment and prevention of viral infcetion a nd cell proliferative disorders; immunotherapy |
| 09/18/2008 | US20080226660 Nucleotide sequences coding human papilloma viral like particles (Hpv 58 L1) for use in designing vaccine for prevention virus associated cell proliferative disorders |
| 09/18/2008 | US20080226651 Envelope protein specific immunoglobulin for use in treatment and prevention human immunodeficieny virus infection |
| 09/18/2008 | US20080226650 Cotinine neutralizing antibody |
| 09/18/2008 | US20080226649 Cytosine/guanine nucleotide sequences for use as therapeutic in treatment of allergy, asthma, cancer, infection, anemia, thrombocytopenia and neutropenia. |
| 09/18/2008 | US20080226645 Methods and compositions for assessment and treatment of asthma |
| 09/18/2008 | US20080226643 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/18/2008 | US20080226642 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/18/2008 | US20080226637 Hemophilus polypeptide for generating immunoglobulins and vaccines for use in prevention and treatment of bacterial infection |
| 09/18/2008 | US20080226634 Tes7 and antibodies that bind thereto |
| 09/18/2008 | US20080226633 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/18/2008 | US20080226628 CDR-Grafted Anti-Tissue Factor Antibodies and Methods of Use Thereof |
| 09/18/2008 | US20080226621 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 09/18/2008 | US20080226620 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226617 Recombinant human arginase functioning as arginine depleting agent in treatment of cell proliferative disorders |
| 09/18/2008 | US20080226607 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226606 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226602 RNA viral vector for use in targeting tumor cell for destruction; antitumor agents and gene therapy |
| 09/18/2008 | US20080226598 Dendritc specific RNA viral plasmid comprising nucleotide sequences coding tumor associated for use in developing cancer vaccine; genetic vaccines |
| 09/18/2008 | US20080226586 Expression vector comprising nucleotide sequences coding cytokine protein for diagnosis, prevention and treatment of thymus disorders |
| 09/18/2008 | US20080226556 Using macrophages;milk fat globulins; epidermal growth factor mutants |
| 09/18/2008 | US20080226551 Transport Molecules Using Reverse Sequence HIV-TAT Polypeptides |
| 09/18/2008 | US20080224099 Carboxylic acid-modified edot for bioconjugation |
| 09/18/2008 | CA2680600A1 Li-rnai involved li suppression in cancer immunotherapy |
| 09/18/2008 | CA2680558A1 Clinical sample preparation on a microfluidic platform |
| 09/17/2008 | EP1970454A2 Single-primer nucleic acid amplification methods |
| 09/17/2008 | EP1970445A1 Method for nucleic acid replication and novel artificial base pairs |
| 09/17/2008 | EP1969144A2 Compositions and methods related to controlled gene expression using viral vectors |
| 09/17/2008 | EP1968998A2 Affinity optimized epha2 agonistic antibodies and methods of use thereof |
| 09/17/2008 | EP1968994A2 Synthetic genomes |
| 09/17/2008 | EP1968612A2 Nucleotide and oligonucleotide prodrugs |
| 09/17/2008 | EP1825263A4 Cellular signaling pathway based assays, reagents and kits |
| 09/17/2008 | EP1758918A4 A method of diagnosing fiv |
| 09/17/2008 | EP1732939A4 Nucleic acid based assays for identification of fc receptor polymorphisms |
| 09/17/2008 | EP1641925B1 Food additive comprising pseudomonas non-maltogenic exoamylase variants |
| 09/17/2008 | EP1481088B1 Polynomial amplification of nucleic acids |
| 09/17/2008 | EP0994951B1 Polynucleotides and their use for detecting resistance to streptogramin a |
| 09/17/2008 | CN101268198A Method for extraction and identification of nucleic acids |
| 09/17/2008 | CN101268188A Novel artificial base pair and use thereof |
| 09/17/2008 | CN101265285A Immunostimulatory nucleic acid molecules |
| 09/17/2008 | CN100419426C Functionalized nanoparticles and methods of use |
| 09/17/2008 | CN100419414C Luminescent detector |
| 09/16/2008 | US7425667 Methods to produce desired proteins in plants |
| 09/16/2008 | US7425625 Carotenoid ketolase genes with improved ketocarotenoid yield |
| 09/16/2008 | US7425624 Sulfotransferase 1A3 sequence variants |
| 09/16/2008 | US7425623 Binding to surface of tumor cell; bacteriophage separation; in situ diagnosis |
| 09/16/2008 | US7425621 Nucleotide sequences coding polypeptides for use in the treatment and prevention of cell proliferation disorders |
| 09/16/2008 | US7425617 Antibodies to the cell cycle regulatory protein p16 |
| 09/16/2008 | US7425615 Protein for use in the treatment of lysosomal storage defects |
| 09/16/2008 | US7425613 Glucose transport proteins for use in identifying modulators which prevent glucose uptake; diabetes diagnostic and therapeutic |
| 09/16/2008 | US7425611 Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use |
| 09/16/2008 | US7425609 PRO4330 polypeptides |
| 09/16/2008 | US7425605 PRO1486 polypeptides |
| 09/16/2008 | US7425545 Antisense oligonucleotide for use in controlling c-reactive protein expression and treatment and prevention of adipocyte differentiation, obesity, hyperlipidemia, atherosclerosis and hypertension |
| 09/16/2008 | US7425544 Modulation of eIF4E expression |
| 09/16/2008 | US7425446 host cells into which a gene encoding an antibody is introduced, which is resistant to a section which recognizes a sugar chain in which fucose is bound to N-acetylglucosamine in a complex N-glycoside-linked sugar chain; antibodies used for diseases having antibody-dependent cell-mediated cytotoxicity |
| 09/16/2008 | US7425436 Covalent tethering of functional groups to proteins and substrates therefor |
| 09/16/2008 | US7425435 Nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) protein for preparation and generation of amino acid for use in foods, cosmetics and medicines; bioremediation; terpenoid biosynthesis |
| 09/16/2008 | US7425434 Allows the above microorganism to use cyclododecanol and cyclododecanone (12-membered ring compounds) as sole carbon source for growth and energy |
| 09/16/2008 | US7425433 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use |
| 09/16/2008 | US7425431 Polony fluorescent in situ sequencing beads |
| 09/16/2008 | US7425429 Method for the identification of tissue-specific regulatory sequences |
| 09/16/2008 | US7425417 Comprises oligomers for detection of long terminal repeats of human lymphadenopathy associated virus and human T-cell leukemia/lymphoma virus; diagnosing viral disease/infection; contacting HIV-1 nucleic acid with capture oligomer and complexing; detecting amplified nucleic acid |
| 09/16/2008 | US7425416 Contacting target sequence and plurality of marker sequences to first and second set of oligonucleotides to anneal first set to target sequence or anneal second set to the marker sequences; elongation, detection; markers include single nucleotide polymorphisms or short tandem repeats |
| 09/16/2008 | US7425414 Method of prognosis of metastasis by detection of FRA12E fragile site within the SMRT gene/locus at chromosome 12q24 |